Detalhe da pesquisa
1.
Mutations involving TGFB and MAPK may be associated with malignancy in granular cell tumors.
Genes Chromosomes Cancer
; 62(5): 301-307, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680529
2.
Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas.
BMC Cancer
; 23(1): 553, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328781
3.
Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.
PLoS Med
; 18(8): e1003734, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464388
4.
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.
Br J Cancer
; 125(4): 528-533, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050255
5.
A Phase II Study of Tumor Ablation in Patients with Metastatic Sarcoma Stable on Chemotherapy.
Oncologist
; 23(7): 760-e76, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29487221
6.
Diagnosis and Treatment of Myxoid Liposarcomas: Histology Matters.
Curr Treat Options Oncol
; 19(12): 64, 2018 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30362022
7.
Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Cancer
; 123(7): 1194-1201, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27875628
8.
Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas.
Mod Pathol
; 28(2): 187-200, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25189642
9.
CSF1 expression in xanthogranulomatous epithelial tumor/keratin-positive giant cell-rich tumor.
Hum Pathol
; 143: 1-4, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993023
10.
Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.
Am Soc Clin Oncol Educ Book
; 44(3): e432242, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710002
11.
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics.
medRxiv
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293154
12.
Novel pathways and molecular targets for the treatment of sarcoma.
Curr Oncol Rep
; 15(4): 378-85, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23661264
13.
Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma.
JCO Precis Oncol
; 7: e2300037, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738543
14.
MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.
Clin Cancer Res
; 29(8): 1592-1604, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799629
15.
A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.
Cancers (Basel)
; 15(9)2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174084
16.
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors.
bioRxiv
; 2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36778419
17.
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma.
J Clin Med
; 12(7)2023 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37048645
18.
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.
Sci Adv
; 9(47): eadg8876, 2023 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38000020
19.
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.
Clin Cancer Res
; 29(17): 3484-3497, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410426
20.
Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.
Cancer Discov
; 13(3): 654-671, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36598417